Loading...
BioSyent Inc.
BIOYF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$8.39
$-0.06(-0.71%)
BioSyent Inc. (BIOYF) Financial Performance & Income Statement Overview
Review BioSyent Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
10.89%
↑ 10.89%
Operating Income Growth
17.16%
↑ 17.16%
Net Income Growth
12.54%
↑ 12.54%
Operating Cash Flow Growth
71.39%
↑ 71.39%
Operating Margin
25.22%
↑ 25.22%
Gross Margin
78.51%
↑ 78.51%
Net Profit Margin
20.43%
↑ 20.43%
ROE
21.76%
↑ 21.76%
ROIC
26.15%
↑ 26.15%
BioSyent Inc. (BIOYF) Income Statement & Financial Overview
Review BioSyent Inc.'s (BIOYF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $8.80M | $9.56M | $8.94M | $7.73M |
| Cost of Revenue | $1.64M | $2.07M | $1.87M | $1.70M |
| Gross Profit | $7.15M | $7.49M | $7.07M | $6.03M |
| Gross Profit Ratio | $0.81 | $0.78 | $0.79 | $0.78 |
| R&D Expenses | $55209.00 | $0.00 | $27669.00 | $24100.00 |
| SG&A Expenses | $4.31M | $4.51M | $4.92M | $3.92M |
| Operating Expenses | $5.15M | $4.75M | $5.14M | $3.94M |
| Total Costs & Expenses | $6.79M | $6.82M | $7.02M | $5.65M |
| Interest Income | $260088.00 | $256890.00 | $238789.00 | $332819.00 |
| Interest Expense | $13971.00 | $14579.00 | $15009.00 | $15593.00 |
| Depreciation & Amortization | $236320.00 | $116843.00 | $121797.00 | $114988.00 |
| EBITDA | $2.50M | $3.11M | $2.29M | $2.54M |
| EBITDA Ratio | $0.28 | $0.33 | $0.26 | $0.33 |
| Operating Income | $2.005M | $2.73M | $1.93M | $2.09M |
| Operating Income Ratio | $0.23 | $0.29 | $0.22 | $0.27 |
| Other Income/Expenses (Net) | $246117.00 | $242311.00 | $223780.00 | $317226.00 |
| Income Before Tax | $2.25M | $2.98M | $2.15M | $2.41M |
| Income Before Tax Ratio | $0.26 | $0.31 | $0.24 | $0.31 |
| Income Tax Expense | $637715.00 | $667210.00 | $569765.00 | $637704.00 |
| Net Income | $1.61M | $2.31M | $1.58M | $1.77M |
| Net Income Ratio | $0.18 | $0.24 | $0.18 | $0.23 |
| EPS | $0.14 | $0.20 | $0.14 | $0.15 |
| Diluted EPS | $0.14 | $0.20 | $0.13 | $0.15 |
| Weighted Avg Shares Outstanding | $11.28M | $11.59M | $11.59M | $11.67M |
| Weighted Avg Shares Outstanding (Diluted) | $11.81M | $11.82M | $11.80M | $11.87M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan